Cheraghlou Shayan, Doudican Nicole A, Criscito Maressa C, Stevenson Mary L, Carucci John A
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
J Am Acad Dermatol. 2023 Nov;89(5):1022-1030. doi: 10.1016/j.jaad.2023.03.049. Epub 2023 Apr 11.
Vulvar squamous cell carcinoma (vSCC) is a rare tumor with a good prognosis when treated at a localized stage. However, once regional/distant metastasis occurs, vSCC can be rapidly fatal. Thus, it is important to identify tumor prognostic features so that high-risk cases can be prioritized for further diagnostic workup and treatment.
To estimate the risk of regional/distant metastasis at presentation and sentinel lymph node status for vSCC based on histopathologic characteristics.
A retrospective cohort study of 15,188 adult vSCC cases from the National Cancer Database diagnosed from 2012 to 2019.
We provide specific estimates of the risk of clinically positive nodes and metastatic disease at presentation and sentinel lymph node positivity according to tumor size, moderate/poor tumor differentiation, and lymph-vascular invasion. These histopathologic factors were all significantly associated with the tested clinical outcomes in a multivariable analysis. Moderate (hazard ratio, 1.190; P < .001) and poor differentiation (hazard ratio, 1.204; P < .001) and lymph-vascular invasion (hazard ratio, 1.465; P < .001) were also associated with significantly poorer overall survival.
Data on disease-specific survival not available in the data set.
We demonstrate the association of the histopathologic characteristics of vSCC with clinically important outcomes. These data may provide individualized information when discussing diagnostic/treatment recommendations, particularly regarding sentinel lymph node biopsy. These data may also guide future staging and risk stratification efforts for vSCC.
外阴鳞状细胞癌(vSCC)是一种罕见肿瘤,局部阶段治疗时预后良好。然而,一旦发生区域/远处转移,vSCC可能迅速致命。因此,识别肿瘤预后特征很重要,以便对高危病例优先进行进一步诊断检查和治疗。
基于组织病理学特征评估vSCC初诊时区域/远处转移风险及前哨淋巴结状态。
对2012年至2019年美国国家癌症数据库中15188例成年vSCC病例进行回顾性队列研究。
我们根据肿瘤大小、中度/低分化以及脉管侵犯情况,提供了初诊时临床阳性淋巴结和转移疾病风险以及前哨淋巴结阳性的具体评估。在多变量分析中,这些组织病理学因素均与所检测的临床结局显著相关。中度(风险比,1.190;P <.001)和低分化(风险比,1.204;P <.001)以及脉管侵犯(风险比,1.465;P <.001)也与总体生存率显著较差相关。
数据集中没有疾病特异性生存数据。
我们证明了vSCC的组织病理学特征与临床重要结局之间的关联。这些数据在讨论诊断/治疗建议时,尤其是在前哨淋巴结活检方面,可能提供个体化信息。这些数据还可能指导未来vSCC的分期和风险分层工作。